Guidance for Industry: Conducting Clinical Trials With Decentralized Elements
Date: September 23, 2024
The Conducting Clinical Trials With Decentralized Elements final guidance has now been released, and provides recommendations for sponsors, investigators, and other interested parties regarding the implementation of decentralized elements in clinical trials.
Read here: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/conducting-clinical-trials-decentralized-elements
Explore More News
Launch of Online Training from ACDM
The Association for Clinical Data Management is delighted to announce the launch of Online . . .
Read More
ACDM 2019 Awards Finalists
The Association for Clinical Data Management are delighted to announce the finalists for . . .
Read More
Castor EDC to Sponsor ACDM19
The Association for Clinical Data Management (ACDM) are delighted to announce that Castor . . .
Read More
Danone Nutricia Research to Sponsor ACDM19
The Association for Clinical Data Management (ACDM) are delighted to announce that . . .
Read More
ACDM19 Conference Programme
The Association for Clinical Data Management is delighted to announce the Full Programme . . .
Read More
Record Number of Abstracts Submitted for ACDM19
The deadline for Abstracts for ACDM19 passed on the 30th September and the Association for . . .
Read More
Phastar Sponsor ACDM19
The Association for Clinical Data Management are delighted to announce that PHASTAR are . . .
Read More
Launch of Annual ACDM Awards
The Association for Clinical Data Management are delighted to announce the introduction of . . .
Read More
